Ladenburg Thalmann Financial Services’s Lisata Therapeutics LSTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$9K Sell
235
-2
-0.8% -$72 ﹤0.01% 4528
2019
Q3
$9K Hold
237
﹤0.01% 4444
2019
Q2
$8K Hold
237
﹤0.01% 4532
2019
Q1
$13K Hold
237
﹤0.01% 4251
2018
Q4
$12K Hold
237
﹤0.01% 4174
2018
Q3
$21K Buy
237
+166
+234% +$13.6K ﹤0.01% 3873
2018
Q2
$6K Hold
71
﹤0.01% 4511
2018
Q1
$6K Hold
71
﹤0.01% 4511
2017
Q4
$4K Buy
71
+67
+1,675% +$3.37K ﹤0.01% 4602
2017
Q3
$0 Sell
4
-7
-64% -$425 ﹤0.01% 4980
2017
Q2
$0 Hold
11
﹤0.01% 4928
2017
Q1
$1K Sell
11
-8
-42% -$554 ﹤0.01% 4719
2016
Q4
$1K Hold
19
﹤0.01% 4672
2016
Q3
$1K Buy
19
+9
+90% +$725 ﹤0.01% 4626
2016
Q2
$1K Hold
10
﹤0.01% 4584
2016
Q1
$1K Hold
10
﹤0.01% 4533
2015
Q4
$1K Hold
10
﹤0.01% 4522
2015
Q3
$1K Hold
10
﹤0.01% 4430
2015
Q2
$3K Hold
10
﹤0.01% 4238
2015
Q1
$5K Buy
10
+9
+900% +$4.88K ﹤0.01% 3978
2014
Q4
$1K Sell
1
-87
-99% -$59.2K ﹤0.01% 4212
2014
Q3
$73K Hold
88
﹤0.01% 1799
2014
Q2
$86K Sell
88
-3
-3% -$2.92K ﹤0.01% 1698
2014
Q1
$96K Sell
91
-13
-13% -$14.1K ﹤0.01% 1529
2013
Q4
$107K Buy
+104
New +$103K ﹤0.01% 1434

Other funds holding LSTA

Ladenburg Thalmann Financial Services's LSTA Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services reduced its Lisata Therapeutics (LSTA) stake by 0.84% in Q4 2019, selling an estimated $72 and leaving 235 shares worth $9K. The position accounts for ﹤0.01% of the portfolio, ranked #4528.

Ladenburg Thalmann Financial Services first reported a position in LSTA in Q4 2013 and has held it in 25 quarters since. The position peaked at $107K in Q4 2013. 23 funds tracked by Wall St. Rank hold LSTA as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 235 shares of Lisata Therapeutics worth $9K as of Q4 2019.
  • Ladenburg Thalmann Financial Services sold 2 Lisata Therapeutics shares in Q4 2019, an estimated $72.
  • Lisata Therapeutics made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #4528 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Lisata Therapeutics in Q4 2013 and has held it in 25 quarters since.
  • Ladenburg Thalmann Financial Services's Lisata Therapeutics position peaked at $107K in Q4 2013.
  • 23 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.